Bioequivalence study of two different dapagliflozin tablet formulations in healthy adult Indian volunteers

Bioequivalence study of two different dapagliflozin tablet formulations in healthy adult Indian volunteers

Objective: To assess the bioequivalence of 10 mg dapagliflozin tablets compared with that of 10 mg Farxiga® (dapagliflozin) tablets of AstraZeneca Pharmaceuticals LP, USA in healthy, adult volunteers under fasting conditions. Materials and Methods: This was an open-label, balanced, randomized, two-t...

Full description

Bibliographic Details
Main Authors: Sanjay Kalra, Supratik Bhattacharya
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Diabetology
Subjects:
fasting condition
pharmacokinetic
reference product
safety
Online Access:http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2022;volume=13;issue=3;spage=235;epage=241;aulast=Kalra

Internet

http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2022;volume=13;issue=3;spage=235;epage=241;aulast=Kalra

Similar Items